Related Experiment Video
Updated: Feb 11, 2026

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
Published on: September 7, 2010
Natural Products with Toll-Like Receptor 4 Antagonist Activity.
Monica Molteni1, Annalisa Bosi1, Carlo Rossetti1
1Dipartimento di Biotecnologie e Scienze della Vita, Università degli Studi dell'Insubria, Via Dunant, 3-21100 Varese, Italy.
Natural compounds from bacteria, cyanobacteria, and plants show potential as Toll-Like Receptor 4 (TLR4) antagonists. These molecules can inhibit TLR4 activation, offering new anti-inflammatory therapeutic strategies for various diseases.
Area of Science:
- Immunology
- Pharmacology
- Natural Product Chemistry
Background:
- Toll-Like Receptors (TLRs) are key innate immune sensors recognizing pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs).
- TLR activation triggers pro-inflammatory responses, contributing to various pathologies including ischemia/reperfusion injury, neuropathic pain, neurodegenerative diseases, and cancer.
- Toll-Like Receptor 4 (TLR4) is a critical mediator in these inflammatory processes.
Purpose of the Study:
- To review natural product-derived TLR4 antagonists.
- To explore molecules from bacteria, cyanobacteria, and plants that target TLR4 activation pathways.
Main Methods:
- Literature review of scientific publications.
- Analysis of studies investigating natural compounds and their effects on TLR4 signaling.
Main Results:
- Several molecules from natural sources demonstrate the ability to antagonize TLR4.
- These natural TLR4 antagonists hold promise for mitigating TLR4-driven inflammation.
Conclusions:
- Natural products offer a promising source of novel TLR4 antagonists.
- Targeting TLR4 with these natural compounds represents a potential therapeutic strategy for inflammatory conditions.
More Related Videos
Related Concept Videos
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

